IOVS Blood
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Neill, B.
Right arrow Articles by Farrar, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Neill, B.
Right arrow Articles by Farrar, G. J.
(Investigative Ophthalmology and Visual Science. 2000;41:2863-2869.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Ribozyme-Based Therapeutic Approaches for Autosomal Dominant Retinitis Pigmentosa

Brian O’Neill, Sophia Millington–Ward, Mary O’Reilly, Gearóid Tuohy, Anna–Sophia Kiang, Paul F. Kenna, Peter Humphries and G. Jane Farrar

From the Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Ireland.

PURPOSE. To design, generate, and compare in vitro a range of hammerhead ribozymes targeting retinal transcripts implicated in autosomal dominant retinitis pigmentosa (adRP) and thereby identify ribozymes that may be valuable as therapeutic agents for adRP. To address mutational heterogeneity in rhodopsin and peripherin-linked adRP using mutation-independent ribozyme-based therapeutic approaches.

METHODS. Ribozyme and cDNAs constructs were cloned into pcDNA3 and expressed in vitro from the T7 promoter. Cleavage reactions were separated on polyacrylamide gels, visualized by autoradiography, and quantified using an instant imager. Ribozymes targeting rhodopsin and peripherin transcripts in a mutation-independent manner (Rz9, Rz10, and Rz40) and a multimeric ribozyme (RzMM) targeting rhodopsin transcripts were evaluated for in vitro activity. Parameters such as Vmax, Km, k2 and k-1 were established for each ribozyme.

RESULTS. Four ribozymes targeting retinal transcripts were evaluated. Mutation-independent ribozymes targeting degenerate sites or untranslated regions in retinal transcripts resulted in cleavage products of predicted size, whereas transcripts from modified replacement genes remained intact. Detailed kinetic evaluation of ribozymes revealed substantial differences in cleavage rates between ribozymes.

CONCLUSIONS. Mutation-independent hammerhead ribozymes targeting rhodopsin and peripherin have been screened in vitro, and a number of extremely efficient ribozymes identified subsequent to detailed kinetic analyses, suggesting that these ribozymes may provide mutation-independent methods of treating adRP. These are the first ribozymes reported that potentially will provide benefit for inherited retinopathies.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
A. Aherne, A. Kennan, P. F. Kenna, N. McNally, D. G. Lloyd, I. L. Alberts, A.-S. Kiang, M. M. Humphries, C. Ayuso, P. C. Engel, et al.
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa
Hum. Mol. Genet., March 15, 2004; 13(6): 641 - 650.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. J.A. Wood, B. Trulzsch, A. Abdelgany, and D. Beeson
Therapeutic gene silencing in the nervous system
Hum. Mol. Genet., October 15, 2003; 12(90002): R279 - 284.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Millington-Ward, C. Allers, G. Tuohy, P. Conget, D. Allen, H. P. McMahon, P. F. Kenna, P. Humphries, and G. J. Farrar
Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta
Hum. Mol. Genet., September 15, 2002; 11(19): 2201 - 2206.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. McNally, P. F. Kenna, D. Rancourt, T. Ahmed, A. Stitt, W. H. Colledge, D. G. Lloyd, A. Palfi, B. O'Neill, M. M. Humphries, et al.
Murine model of autosomal dominant retinitis pigmentosa generated by targeted deletion at codon 307 of the rds-peripherin gene
Hum. Mol. Genet., May 1, 2002; 11(9): 1005 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. J. Caplen, J. P. Taylor, V. S. Statham, F. Tanaka, A. Fire, and R. A. Morgan
Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference
Hum. Mol. Genet., January 1, 2002; 11(2): 175 - 184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology